Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
20.59 USD | -0.58% | -12.66% | -43.42% |
May. 09 | RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk | MT |
May. 08 | Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.42% | 1.11B | |
+5.17% | 111B | |
+12.34% | 105B | |
-12.85% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-11.15% | 16.96B | |
+4.93% | 13.7B | |
+36.54% | 12.45B |
- Stock Market
- Equities
- PRTA Stock
- News Prothena Corporation plc
- RBC Lifts Price Target on Prothena to $52 From $45, Says Biogen/Eisai's Lecanemab Data Clear Way for Anti-Amyloid Drug Class in Alzheimer's; Outperform, Speculative Risk Kept